Michael D Stifelman

Biosketch / Results /

Michael D Stifelman, M.D.

Associate Professor; Service Chief at NYUHC; Dir Min Inv Urology Laparscopy & Robotics
Department of Urology (Urology)
NYU Urology Associates

Clinical Addresses

150 EAST 32ND STREET
2ND FLOOR
NEW YORK, NY 10016
Hours: Wed. 8:30 - 6:30; Thu. 8 - 1
Phone: 646-825-6325
Fax: 646-825-6399

« Back to Results

Medical Specialties

Cancer, Urology

Medical Expertise

Kidney Cancer, Prostate Cancer, Laparoscopy, Bladder Cancer, Minimally Invasive Surgery, Reconstructive Surgery, Laser Surgery, Prostate Disorders, Urologic Oncology, Robotic Surgery, BPH (Prostatic Hypertrophy)

Clinical Responsibilities

Dr. Stifelman completed his general surgery and urologic training at New York Presbyterian?Columbia and an Endourology/Laparoscopic Fellowship at New York Presbyterian-Cornell. He was recruited in 2000 to NYU Langone Medical Center as the Director of Minimally Invasive Urologic Surgery. Since joining NYU, Dr. Stifelman has been appointed Chief of the Urology Service at Tisch Hospital and Director of Robotic Surgery at NYU Langone Medical Center. His clinical focus is on the use of robotic and laparoscopic surgical techniques to treat diseases of the genitourinary tract. He has performed nearly 1,000 robotic and laparoscopic procedures and has pioneered over a dozen minimally invasive surgeries. Academically, Dr. Stifelman focuses on developing and evaluating new technologies and defining their exact roles in the operating room. He continues to create standardized teaching techniques to train residents and practicing surgeons in the latest minimally invasive surgical techniques. He is on Faculty of many courses including the American Urologic Association and the International Robotic Urologic Symposium. Each year he travels as a visiting surgeon both nationally and internationally disseminating advanced robotic techniques. He has written numerous book chapters on advanced robotic and laparoscopic procedures and has authored over 100 scientific articles and abstracts on robotic and laparoscopic surgery.

Chief of the Urology Service at NYU Medical Center. Faculty member of the American Urologic Association Post Graduate Education division. Reviewer for the Journal of Urology, Urology and the Journal of Endourology.; Kidney Stones, Laporascopic Surgery, Laser Surgery, Kidney cancer; Prostate Cancer;

Languages

Spanish

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, Cigna HMO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, MULTIPLAN/PHCS PPO, Medicare, NYS EMPIRE PLAN, OXFORD EXCHANGE, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, Tricare, UHC EPO, UHC HMO, UHC POS, UHC PPO, UHC TOP TIER, UNITED EXCHANGE- COMPASS

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2011 — Ab Urology - Urology

Education

1989-1993 — Albert Einstein College of Medicine, Medical Education
1993-1995 — Columbia-Presbyterian Medical Center (General Surgery), Internship
1993-1995 — Columbia-Presbyterian Medical Center (General Surgery), Residency Training
1995-1999 — Columbia-Presbyterian Medical Center (Urology), Residency Training
1999-2000 — Cornell University Medical Center ([None or N/A]), Clinical Fellowships

« Back to Results

Research Interests

Dr. Stifelman is involved in many areas of research including molecular biology, biomedical engineering and clinical research. His focus in molecular biology has been in the development of tumor markers for prostate and kidney cancer. He was a co-investigator on several papers examining the role of RT-PCR of PSA for the clinical staging of prostate cancer and the use of enhanced RT-PCR assay for MN/CA9 to detect renal cell carcinoma cells in the peripheral blood. Publications of these works include Cancer and Cancer Research. In terms of biomedical engineering Dr. Stifelman has several patents for ureteral tissue expansion catheters which allow segments of ureter to be dilated over time. The increased ureteral surface area created by tissue expansion may be utilized to repair ureteral strictures, replace disease segments of the ureter, or potentially create an entirely new bladder. This pioneering work has led to several publications and an IRB approved clinical trial which is underway. Recently he has focused his efforts in developing a translational research program that can test new technologies that may be brought into the clinical arena. Currently being evaluated are different biosealants which may be used to perform a sutureless laparoscopic partial nephrectomy in an attempt to simplify this advanced complex procedure. As a clinical researcher Dr. Stifelman has published extensively on the role of laparoscopy and robotics in urology. He has created an extensive laparoscopic/robotic database which is being utilized to better define the role of these new minimally invasive techniques and technologies within urologic surgery. He has written book chapters on advanced laparoscopic and robotic procedures and has authored or co-authored over 50 scientific articles and abstracts on laparoscopic and robotic surgery. He has been presented his research, has taught post-graduate training courses and has been a visiting professor both nationally and internationally. Dr. Stifelman currently serves as a reviewer for the Journal of Urology, Urology and the Journal of Endourology.